{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T02:50:13Z","timestamp":1788922213841,"version":"build-2803163510"},"reference-count":50,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,30]],"date-time":"2025-03-30T00:00:00Z","timestamp":1743292800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009337","name":"Saitama Medical University","doi-asserted-by":"publisher","award":["21H02856"],"award-info":[{"award-number":["21H02856"]}],"id":[{"id":"10.13039\/501100009337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003086","name":"Eusko Jaurlaritza","doi-asserted-by":"publisher","award":["IT1512\/22"],"award-info":[{"award-number":["IT1512\/22"]}],"id":[{"id":"10.13039\/501100003086","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2019-106404RB-100"],"award-info":[{"award-number":["PID2019-106404RB-100"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["SAF-2017-88126-R"],"award-info":[{"award-number":["SAF-2017-88126-R"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["201129918"],"award-info":[{"award-number":["201129918"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004200","name":"Olle Engkvists Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmacological Sciences"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.jphs.2025.03.014","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T12:18:49Z","timestamp":1743596329000},"page":"131-138","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Receptor-mediated Gi-3 activation in mammalian and human brain membranes: Reestablishment method and its application to nociceptin\/orphanin FQ opioid peptide (NOP) receptor\/Gi-3 interaction"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1792-028X","authenticated-orcid":false,"given":"Yuji","family":"Odagaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Honda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Javier","family":"Meana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis F.","family":"Callado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas A.","family":"Garc\u00eda-Sevilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikl\u00f3s","family":"Palkovits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dasiel Oscar","family":"Borroto-Escuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kjell","family":"Fuxe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jphs.2025.03.014_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0304-4157(90)90007-Y","article-title":"Receptor-effector coupling by G proteins","volume":"1031","author":"Birnbaumer","year":"1990","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.jphs.2025.03.014_bib2","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1146\/annurev.bi.56.070187.003151","article-title":"G proteins: transducers of receptor-generated signals","volume":"56","author":"Gilman","year":"1987","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.jphs.2025.03.014_bib3","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.lfs.2003.07.005","article-title":"The [35S]GTP\u03b3S binding assay: approaches and applications in pharmacology","volume":"74","author":"Harrison","year":"2003","journal-title":"Life Sci"},{"key":"10.1016\/j.jphs.2025.03.014_bib4","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1111\/j.1476-5381.2010.00963.x","article-title":"Use of the GTP\u03b3S ([35S]GTP\u03b3S and Eu-GTP\u03b3S) binding assay for analysis of ligand potency and efficacy at G protein-coupled receptors","author":"Strange","year":"2010","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib5","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.tips.2004.06.003","article-title":"The antibody-capture [35S]GTP\u03b3S scintillation proximity assay: a powerful emerging technique for analysis of GPCR pharmacology","volume":"25","author":"DeLapp","year":"2004","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jphs.2025.03.014_bib6","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s00702-011-0742-2","article-title":"Muscarinic acetylcholine receptor-mediated activation of Gq in rat brain membranes determined by guanosine-5\u2019-O-(3-[35S]thio)triphosphate ([35S]GTP\u03b3S) binding using an anti-G protein scintillation proximity assay","volume":"119","author":"Odagaki","year":"2012","journal-title":"J Neural Transm"},{"key":"10.1016\/j.jphs.2025.03.014_bib7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00210-013-0887-7","article-title":"Pharmacological characterization of M1 muscarinic acetylcholine receptor-mediated Gq activation in rat cerebral cortical and hippocampal membranes","volume":"386","author":"Odagaki","year":"2013","journal-title":"Naunyn-Schmiedebergs Arch Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib8","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000351745","article-title":"Activation of Gq proteins coupled with 5-HT2 receptors in rat cerebral cortical membranes assessed by antibody-capture scintillation proximity assay\/[35S]GTP\u03b3S binding","volume":"92","author":"Odagaki","year":"2013","journal-title":"Pharmacology"},{"key":"10.1016\/j.jphs.2025.03.014_bib9","first-page":"97","article-title":"Guanosine-5\u2019-O-(3-[35S]thio)triphosphate ([35S]GTP\u03b3S) binding\/immunoprecipitation assay using magnetic beads coated with anti-G\u03b1 antibody in mammalian brain membranes","volume":"vol. 144","author":"Odagaki","year":"2019"},{"key":"10.1016\/j.jphs.2025.03.014_bib10","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.ejphar.2015.07.049","article-title":"Adenosine A1 receptors are selectively coupled to G\u03b1i-3 in postmortem human brain cortex: guanosine-5\u2019-O-(3-[35S]thio)triphosphate ([35S]GTP\u03b3S) binding\/immunoprecipitation study","volume":"764","author":"Odagaki","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib11","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s11302-018-9603-x","article-title":"Functional coupling between adenosine A1 receptors and G-proteins in rat and postmortem human brain membranes determined with conventional guanosine-5\u2019-O-(3-[35S]thio)triphosphate ([35S]GTP\u03b3S) binding or [35S]GTP\u03b3S\/immunoprecipitation assay","volume":"14","author":"Odagaki","year":"2018","journal-title":"Purinergic Signal"},{"key":"10.1016\/j.jphs.2025.03.014_bib12","article-title":"US government issues historic $3.5-million fine over animal welfare","author":"Reardon","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.jphs.2025.03.014_bib13","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1016\/S0014-2999(99)00822-5","article-title":"A potent and highly selective nonpeptidyl nociceptin\/orphanin FQ receptor (ORL1) antagonist: J-113397","volume":"387","author":"Ozaki","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib14","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0014-2999(00)00520-3","article-title":"In vitro and in vivo pharmacological characterization of J-113397, a potent and selective non-peptidyl ORL1 receptor antagonist","volume":"402","author":"Ozaki","year":"2000","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib15","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1432-1033.1989.tb15266.x","article-title":"Muscarinic acetylcholine receptor-stimulated binding of guanosine 5\u2019-O-(3-thiotriphosphate) to guanine-nucleotide-binding proteins in cardiac membranes","volume":"186","author":"Hilf","year":"1989","journal-title":"Eur J Biochem"},{"key":"10.1016\/j.jphs.2025.03.014_bib16","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0022-3565(24)38222-9","article-title":"Determination of [35S]guanosine-5\u2019-O-(3-thio)triphosphate binding mediated by cholinergic muscarinic receptors in membranes from Chinese hamster ovary cells and rat striatum using an anti-G protein scintillation proximity assay","volume":"289","author":"DeLapp","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.jphs.2025.03.014_bib17","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1124\/mol.62.3.578","article-title":"Differential activation of Gq\/11 and Gi3 proteins at 5-hydroxytryptamine2C receptors revealed by antibody capture assays: influence of receptor reserve and relationship to agonist-directed trafficking","volume":"62","author":"Cussac","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ejphar.2003.11.077","article-title":"Characterisation of Gs activation by dopamine D1 receptors using an antibody capture assay: antagonist properties of clozapine","volume":"485","author":"Cussac","year":"2004","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib19","doi-asserted-by":"crossref","first-page":"415","DOI":"10.3389\/fphar.2016.00415","article-title":"Biased agonism of three different cannabinoid receptor agonists in mouse brain cortex","volume":"7","author":"Diez-Alarcia","year":"2016","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib20","doi-asserted-by":"crossref","first-page":"4476","DOI":"10.1021\/acschemneuro.9b00302","article-title":"Big data challenges targeting proteins in GPCR signaling pathways; combining PTML-ChEMBL models and [35S]GTP\u03b3S binding assays","volume":"10","author":"Diez-Alarcia","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/j.jphs.2025.03.014_bib21","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.bcp.2011.10.018","article-title":"The inverse agonist effect of rimonabant on G protein activation is not mediated by the cannabinoid CB1 receptor: evidence from postmortem human brain","volume":"83","author":"Erdozain","year":"2012","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.ejphar.2008.04.039","article-title":"Actions of novel agonists, antagonists and antipsychotic agents at recombinant rat 5-HT6 receptors: a comparative study of coupling to G\u03b1s","volume":"588","author":"Dupuis","year":"2008","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib23","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/j.euroneuro.2019.10.013","article-title":"Serotonin 5-HT2A receptor expression and functionality in postmortem frontal cortex of subjects with schizophrenia: selective biased agonism via G\u03b1i1-proteins","volume":"29","author":"Garc\u00eda-Bea","year":"2019","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib24","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/s41386-018-0076-y","article-title":"Chronic cannabis promotes pro-hallucinogenic signaling of 5-HT2A receptors through Akt\/mTOR pathway","volume":"43","author":"Ibarra-Lecue","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jphs.2025.03.014_bib25","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1124\/mol.106.029769","article-title":"Native rat hippocampal 5-HT1A receptors show constitutive activity","volume":"71","author":"Martel","year":"2007","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib26","doi-asserted-by":"crossref","first-page":"4307","DOI":"10.1038\/s41467-024-48196-2","article-title":"G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits","volume":"15","author":"Kossatz","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/j.jphs.2025.03.014_bib27","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1124\/mol.106.022756","article-title":"Regional differences in the coupling of 5-hydroxytryptamine-1A receptors to G proteins in the rat brain","volume":"70","author":"Mannoury","year":"2006","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib28","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.neuropharm.2006.10.021","article-title":"Dopamine D1 receptor coupling to Gs\/olf and Gq in rat striatum and cortex: a scintillation proximity assay (SPA)\/antibody-capture characterization of benzazepine agonists","volume":"52","author":"Mannoury la Cour","year":"2007","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.jphs.2025.03.014_bib29","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1471-4159.2007.05131.x","article-title":"Influence of positive allosteric modulators on GABAB receptor coupling in rat brain: a scintillation proximity assay characterisation of G protein subtypes","volume":"105","author":"Mannoury la Cour","year":"2008","journal-title":"J Neurochem"},{"key":"10.1016\/j.jphs.2025.03.014_bib30","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1002\/syn.20587","article-title":"An immunocapture\/scintillation proximity analysis of G\u03b1q\/11 activation by native serotonin (5-HT)2A receptors in rat cortex: blockade by clozapine and mirtazapine","volume":"63","author":"Mannoury La Cour","year":"2009","journal-title":"Synapse"},{"key":"10.1016\/j.jphs.2025.03.014_bib31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.euroneuro.2020.05.004","article-title":"Pimavanserin exhibits serotonin 5-HT2A receptor inverse agonism for G\u03b1i1- and neutral antagonism for G\u03b1q\/11-proteins in human brain cortex","volume":"36","author":"Muneta-Arrate","year":"2020","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib32","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1124\/mol.62.3.590","article-title":"Antibody capture assay reveals bell-shaped concentration-response isotherms for h5-HT1A receptor-mediated G\u03b1i3 activation: conformational selection by high-efficacy agonists, and relationship to trafficking of receptor signaling","volume":"62","author":"Newman-Tancredi","year":"2002","journal-title":"Mol Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib33","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.cellsig.2010.08.002","article-title":"Competitive interaction of 5-HT1A receptors with G-protein subtypes in CHO cells demonstrated by RNA interference","volume":"23","author":"Rauly-Lestienne","year":"2011","journal-title":"Cell Signal"},{"key":"10.1016\/j.jphs.2025.03.014_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1124\/pr.114.009209","article-title":"Nociceptin\/Orphanin FQ receptor structure, signaling, ligands, functions, and interactions with opioid systems","volume":"68","author":"Toll","year":"2016","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.jphs.2025.03.014_bib35","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1038\/377532a0","article-title":"Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor","volume":"377","author":"Meunier","year":"1995","journal-title":"Nature"},{"key":"10.1016\/j.jphs.2025.03.014_bib36","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1126\/science.270.5237.792","article-title":"Orphanin FQ: a neuropeptide that activates an opioidlike G protein-coupled receptor","volume":"270","author":"Reinscheid","year":"1995","journal-title":"Science"},{"key":"10.1016\/j.jphs.2025.03.014_bib37","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0196-9781(00)00227-8","article-title":"Tissue distribution of the opioid receptor-like (ORL1) receptor","volume":"21","author":"Mollereau","year":"2000","journal-title":"Peptides"},{"key":"10.1016\/j.jphs.2025.03.014_bib38","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0014-5793(97)00031-8","article-title":"Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma x glioma NG108-15 hybrid cells","volume":"403","author":"Ma","year":"1997","journal-title":"FEBS Lett"},{"key":"10.1016\/j.jphs.2025.03.014_bib39","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1046\/j.1471-4159.1998.71052203.x","article-title":"Pertussis toxin-insensitive signaling of the ORL1 receptor: coupling to Gz and G16 proteins","volume":"71","author":"Chan","year":"1998","journal-title":"J Neurochem"},{"key":"10.1016\/j.jphs.2025.03.014_bib40","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1097\/00001756-199705260-00024","article-title":"Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: activation of inhibitory G protein and homologous desensitization","volume":"8","author":"Cheng","year":"1997","journal-title":"Neuroreport"},{"key":"10.1016\/j.jphs.2025.03.014_bib41","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0014-2999(97)01227-2","article-title":"Nociceptin activation of the human ORL1 receptor expressed in Chinese hamster ovary cells: functional homology with opioid receptors","volume":"336","author":"Fawzi","year":"1997","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/j.jphs.2025.03.014_bib42","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0304-3940(97)00807-0","article-title":"Characterization of nociceptin-stimulated in situ [35S]GTP\u03b3S binding in comparison with opioid agonist-stimulated ones in brain regions of the mice","volume":"237","author":"Shimohira","year":"1997","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.jphs.2025.03.014_bib43","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1097\/00001756-199602290-00012","article-title":"Identification of opioid receptor-like (ORL1) peptide-stimulated [35S]GTP\u03b3S binding in rat brain","volume":"7","author":"Sim","year":"1996","journal-title":"Neuroreport"},{"key":"10.1016\/j.jphs.2025.03.014_bib44","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/bcpt.13183","article-title":"Optimization and pharmacological characterization of receptor-mediated Gi\/o activation in postmortem human prefrontal cortex","volume":"124","author":"Odagaki","year":"2019","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/j.jphs.2025.03.014_bib45","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.pharmthera.2013.10.011","article-title":"The biology of Nociceptin\/Orphanin FQ (N\/OFQ) related to obesity, stress, anxiety, mood, and drug dependence","volume":"141","author":"Witkin","year":"2014","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jphs.2025.03.014_bib46","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s40263-021-00821-0","article-title":"The NOP receptor system in neurological and psychiatric disorders: discrepancies, peculiarities and clinical progress in developing targeted therapies","volume":"35","author":"Toll","year":"2021","journal-title":"CNS Drugs"},{"key":"10.1016\/j.jphs.2025.03.014_bib47","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.pharmthera.2013.05.008","article-title":"Nociceptin\/orphanin FQ receptor antagonists as innovative antidepressant drugs","volume":"140","author":"Gavioli","year":"2013","journal-title":"Pharmacol Ther"},{"key":"10.1016\/j.jphs.2025.03.014_bib48","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1038\/npp.2015.348","article-title":"A selective nociceptin receptor antagonist to treat depression: evidence from preclinical and clinical studies","volume":"41","author":"Post","year":"2016","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.jphs.2025.03.014_bib49","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.tips.2007.06.005","article-title":"The evasive nature of drug efficacy: implications for drug discovery","volume":"28","author":"Galandrin","year":"2007","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.jphs.2025.03.014_bib50","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1039\/D1MD00041A","article-title":"Comprehensive overview of biased pharmacology at the opioid receptors: biased ligands and bias factors","volume":"12","author":"De Neve","year":"2021","journal-title":"RSC Med Chem"}],"container-title":["Journal of Pharmacological Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000350?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347861325000350?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T14:02:14Z","timestamp":1778594534000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347861325000350"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S1347861325000350"],"URL":"https:\/\/doi.org\/10.1016\/j.jphs.2025.03.014","relation":{},"ISSN":["1347-8613"],"issn-type":[{"value":"1347-8613","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Receptor-mediated Gi-3 activation in mammalian and human brain membranes: Reestablishment method and its application to nociceptin\/orphanin FQ opioid peptide (NOP) receptor\/Gi-3 interaction","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmacological Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jphs.2025.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V. on behalf of Japanese Pharmacological Society.","name":"copyright","label":"Copyright"}]}}